Comparative study of lymphoedema with axillary node dissection versus axillary node sampling with radiotherapy in patients undergoing breast conservation surgery

被引:24
作者
Mathew, J.
Barthelmes, L.
Neminathan, S.
Crawford, D.
机构
[1] Ysbyty Gwynedd, Bangor, Gwynedd
来源
EJSO | 2006年 / 32卷 / 07期
关键词
axillary sampling; axillary dissection; axillary radiotherapy; breast cancer; lymphoedema;
D O I
10.1016/j.ejso.2006.04.019
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Aims: Our aim was to compare the incidence of lymphoedema in two groups of patients undergoing breast conservation surgery; one undergoing axillary sampling and radiotherapy to patients with positive axillary nodes, and the other undergoing axillary clearance. Methods: Retrospective review of records of two sequential groups of patients; one undergoing axillary sampling between January 1994 and December 1998 (Group 1) and the other undergoing axillary clearance between January 2000 and December 2002 (Group 2). Both groups had minimum of 2 years follow-up. Results: Three hundred and twelve patients were included in Group 1 and 194 in Group 2.2.2% of the patients in Group 1 developed lymphoedema compared to 12.3% in Group 2. This was statistically significant with a P value = 0.0001. In the node-positive patients, the incidence of lymphoedema in Group 1 was 6.2% compared to 15.4% in Group 2, although the differences were not statistically significant with P = 0.17. Conclusions: The incidence of lymphoedema in the axillary sampling group was low, although the differences were less pronounced in the node-positive patients. The effectiveness of radiotherapy as an alternative to full axillary dissection among patients with positive nodes is currently under investigation in randomised controlled trials. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:729 / 732
页数:4
相关论文
共 33 条
[1]
Armer JM, 2004, LYMPHOLOGY, V37, P73
[2]
The role of lymph node sampling and radiotherapy in the management of the axilla in early breast cancer [J].
Barthelmes, L ;
Al-Awa, A ;
Murali-Krishnan, VP ;
Crawford, DJ .
BREAST, 2002, 11 (03) :236-240
[3]
CADY B, 1994, CANCER, V73, P505, DOI 10.1002/1097-0142(19940201)73:3<505::AID-CNCR2820730302>3.0.CO
[4]
2-B
[5]
CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO
[6]
2-H
[7]
Management of the axilla in operable breast cancer treated by breast conservation: a randomized clinical trial [J].
Chetty, U ;
Jack, W ;
Prescott, RJ ;
Tyler, C ;
Rodger, A .
BRITISH JOURNAL OF SURGERY, 2000, 87 (02) :163-169
[8]
AXILLARY DISSECTION IN BREAST-CANCER - WHEN, WHY, HOW MUCH, AND FOR HOW LONG - ANOTHER OPERATION SOON TO BE EXTINCT [J].
DECKERS, PJ .
JOURNAL OF SURGICAL ONCOLOGY, 1991, 48 (04) :217-219
[9]
Does information from axillary dissection change treatment in clinically node-negative patients with breast cancer? - An algorithm for assessment of impact of axillary dissection [J].
Dees, EC ;
Shulman, LN ;
Souba, WW ;
Smith, BL .
ANNALS OF SURGERY, 1997, 226 (03) :279-286
[10]
Prospective evaluation of the morbidity of axillary clearance for breast cancer [J].
Duff, M ;
Hill, ADK ;
McGreal, G ;
Walsh, S ;
McDermott, EW ;
O'Higgins, NJ .
BRITISH JOURNAL OF SURGERY, 2001, 88 (01) :114-117